Updated: Fri, 10/11/2024 - 12:00

Campus/building access, classes and work will return to usual conditions, as of Saturday, Oct. 12. See Campus Public Safety website for details.


Accès au campus et aux immeubles, cours et modalités de travail : retour à la normale à compter du samedi 12 octobre. Complément d’information : Direction de la protection et de la prévention.

Event

Management of Disease Modifying Interventions in Alzheimer's

Tuesday, December 3, 2024 13:00to16:15
Montreal Neurological Institute de Grandpre Communications Centre, 3801 rue University, Montreal, QC, H3A 2B4, CA

Management of Disease Modifying Interventions in Alzheimer's 


To attend in person, register here (link coming soon)


Suzanne Schindler, MD, PhD

Department of Neurology, Washington University School of Medicine

Talk: Biomarkers for Detection of AD and Indications of Anti-Amyloid Therapy

Abstract: TBD


Alireza Atri, MD, PhD

Department of Neurology, Harvard Medical School

Talk: Amyloid Related Imaging Abnormalities (ARIA)

Abstract: TBD

 

Programme

Tuesday, December 3, 2024

13:00

Welcome & Opening Remarks

Pedro Rosa-Neto, MD, PhD

14:00

Biomarkers for Detection of AD and Indications of Anti-Amyloid Therapy

Suzanne Schindler, MD, PhD

14:45 Refreshment Pause
15:15

Amyloid Related Imaging Abnormalities (ARIA)

Alireza Atri, MD, PhD

16:00

Closing Remarks

Pedro Rosa-Neto, MD, PhD

16:15 Cocktail & Networking

Sponsors

Logo for Eisai

Logo for Lilly

Logo for Roche

Organizing Committee

Pedro Rosa-Neto
Director, Translational Neuroimaging Laboratory, Douglas Research Centre

Debbie Rashcovsky
Neuro Events Team Lead

Back to top